Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001867348 | SCV002127810 | uncertain significance | Retinoblastoma | 2021-07-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with RB1-related conditions. This variant is present in population databases (rs568421803, ExAC 0.01%). This sequence change replaces proline with serine at codon 357 of the RB1 protein (p.Pro357Ser). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and serine. |
Gene |
RCV004591606 | SCV005079145 | uncertain significance | not provided | 2023-12-05 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |